“Visfatin Promotes Renal Cell Carcinoma Progression: Evidence from Clinical Samples and Cell Line Models”. 2025. Journal of Kidney Cancer 12 (3): 58-65. https://doi.org/10.15586/jkcvhl.v12i3.427.